233 event(s) found
ASCO GI 2026
The ASCO Gastrointestinal Cancers Symposium is the leading global forum for the latest high-impact science and solution-focused strategies in the GI cancers field. You don’t want to miss it!
AACR Special Conference: Fusion-Positive Cancer: From Discovery to Therapy
Hosted by the American Association for Cancer Research (AACR), the AACR Special Conference on Fusion-Positive Cancers 2026 will bring together leading researchers, clinicians, and translational scientists to discuss the latest advances in fusion oncogene biology, carcinogenesis, and targeted therapeutic strategies. This premier event will explore the genetic and molecular mechanisms driving fusion-driven malignancies, highlighting key topics such as tumor modeling, condensate biology, gene regulatory networks, and novel therapeutic approaches, including small molecule inhibitors, targeted protein degradation, and CRISPR-based technologies. Through plenary sessions, keynote lectures, and poster presentations, attendees will engage in discussions on how cutting-edge research is shaping the future of fusion-positive cancer diagnosis and treatment.
Congress of the French Society for Pediatric Hematology and Immunology (SHIP)
In French: "Ce rendez-vous annuel est l’occasion de renforcer nos liens, partager nos connaissances et d’ouvrir ensemble de nouvelles perspectives pour la prise en charge de nos petits patients.Le programme scientifique de cette édition s’annonce particulièrement riche et stimulant. Pendant ces deux jours, nous aborderons trois grandes thématiques : les neutropénies, l’immunologie et les pathologies plaquettaires dans leurs aspects cliniques et génétiques. Le patient étant au cœur de notre pratique, il nous a semblé indispensable de renouveler les sessions d’éducation thérapeutique afin de partager nos expériences."
27th World Congress on Pediatric Oncology and Cancer Care
Pediatric Cancer Innovations: Data, Discovery, and Digital Transformation
Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy
This virtual conference will explore a seemingly paradoxical approach to cancer therapy, based on the deliberate hyper-activation of cancer-relevant signalling pathways. Accumulating evidence suggests that this leads to cell death caused by a further activation of cellular stress responses. Target audience: Scientists in academia and industry who are interested in a fundamentally and radically different approach to cancer therapy.
4th ParKourS conference: "Des parcours à réinventer"
In French: "Le congrès ParKourS – Agir pour améliorer le parcours de soins en oncologie et hématologie réunira représentants des institutions, professionnels de santé, chercheurs, patients et acteurs engagés dans l’accompagnement des patients pour échanger autour d’initiatives qui améliorent le parcours patient et contribuent à l’évolution des pratiques en onco-hématologie. Cette année, la thématique « Des parcours à réinventer » explorera les enjeux de l’organisation des soins face aux évolutions démographiques, mais aussi les leviers pour améliorer l’accès aux soins de support et diminuer les inégalités d’accès aux soins et aux innovations. Il questionnera aussi le profil des patients de demain, la détection précoce des rechutes, le rôle et le soutien des aidants, l’intégration des professionnels de santé de ville dans le suivi, ou encore l’importance de la décision médicale partagée pour impliquer davantage les patients."
SOHO Asia 2026
SOHO Asia 2026 is a regional hematologic oncology conference focusing on scientific exchange and clinical advances in leukemia, lymphoma, and related blood disorders across Asia-Pacific.
Northern California Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
SIO 2026 Annual Scientific Meeting
Dive into an education-packed extravaganza where you can attend expert-led sessions, discover new practices, forge connections with fellow IO professionals, and immerse yourself in the charming beauty of this southern city.
1st CRCM Symposium
For two and a half days, scientists and clinicians from around the world will gather to discuss translational oncology exploring therapeutic innovation, tumor biology, microenvironmental dynamics, and new treatment strategies.
3rd PSCC Innovation Forum
Join us for a day of oncology innovation, scientific exchange, and ecosystem collaboration, bringing together the leading minds shaping the future of cancer care. On the agenda: Expert talks and cutting-edge insights into the latest breakthroughs in oncology Dynamic networking with academia, industry leaders, investors, and public stakeholders Start-up pitches from the most promising companies supported by PSCC Real-world collaboration stories between SMEs, large companies and investors in biotech and medtech The 2025 edition gathered over 550 participants - don’t miss your chance to be part of the next one! More information and website are coming soon...
WORD+ 2026 (4th Annual World Organoid and Organ-on-a-chip Research Day+)
WORD+ 2026: Simply the event for organoid and organ-on-a-chip researchers!
ACCELERATE Annual Conference: Shifting Gears in Paediatric Cancer Innovation
The ACCELERATE Annual Conference is THE EVENT of the year! It offers the perfect opportunity for discussion, knowledge-sharing, networking and engagement with our international, multi-stakeholder community! Speakers present and discuss clinical/preclinical pediatric oncology research, evolutions in the regulatory landscape worldwide, and other key challenges in the path toward accelerating the development of new and more innovative therapies for children and adolescents with cancer. ACCELERATE work progress is monitored, proposals are agreed and launched (new working groups, scientific publications, etc.), and new challenges are identified. During the previous editions, new features have been introduced to make the event even more interactive and engaging for our participants! Breakout sessions on emerging, hot topics are addressed in focused groups to define concrete actions stemming from the discussion.
ASTCT & CIBMTR 2026 Tandem Meetings: Transplantation & Cellular Therapy
The Tandem Meetings are a multidisciplinary event highlighting the latest research and breakthroughs in the evolving field of hematopoietic cell transplantation (HCT), cellular therapy and gene therapy.
ABG 34th Annual Scientific Meeting
ABG 34th Annual Scientific Meeting organized by ABG
ESMO Summit Africa 2026
The ESMO Summit Africa 2026 is a three-day educational event with presentations focused on several key disease sites. Created for oncology professionals in Africa by international and local key opinion leaders, the Summit will put into context the most significant treatment advances presented at the ESMO annual Congress. Summit Objectives: To provide the oncology community with a summary of the most significant treatment advances presented at the ESMO Congresses; To review the current standard of care for key malignancies from a local and international perspective; and To discuss the current controversies in the management of specific cancers. Target Audience: Medical and clinical oncologists, pharmacists, nurses, students, fellows, residents, general practitioners in oncology and other oncology healthcare professionals.
LyFE - Lymphoma Forum of Excellence "What's new in lymphoid neoplasias?"
The LyFE Course, held annually in Bellinzona, Switzerland, is a specialized program focused on lymphoid neoplasias, including myelomas. The course aims to provide participants with comprehensive and up-to-date knowledge in this complex medical field. Designed by lymphoma specialists, it offers an in-depth educational experience for professionals seeking to advance their understanding of these diseases. Since 2004, the event is organized by the Foundation for the Institute of Oncology Research (IOR).
Advanced Therapies Week 2026
Now in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States. Bringing together leaders in research, therapeutic development, and advanced manufacturing. Get connected with the cell and gene therapy ecosystem.
La thérapie à pression négative en chirurgie mammaire
In French: "Programme : 1. La TPN pour la prévention des complications en chirurgie mammaire ( Dr Gabrielle Selmes; 2. Complications des reconstructions par lambeaux : apport de la TPN Dr Clémentine Jankowski; 3. Complications des reconstructions par implant : apport de la TPN Dr Elodie Gauroy; 4. Mise en place et suivi de la TPN : enjeu et organisations en soins courant Gabrielle Selmes, Elodie Gauroy & Clémentine Jankowski; 5. Débat & discussion - Réponses aux questions".
Signalling Circuits in Cancer - Virtual Event
This conference will focus on basic mechanisms controlling cancer cell signalling circuits at the transcriptome, proteome and phosphoproteome levels as well as emerging concepts in cancer cell signalling. Target audience: Scientists in academia and industry who are interested in most recent developments in non-genetic signalling mechanisms and their roles in cancer progression and therapy resistance. The conference will focus on the mechanistic aspects of post translational and transcriptional regulation of cancer cell signalling, as well as OMICS-based understanding of cancer cell signalling circuits and thereby opens novel insights also to development of novel cancer therapies and diagnostics.
EBMT-EHA 8th European CAR T-cell Meeting
We are delighted to welcome you to the 8th edition of the jointly organised EBMT and EHA European CAR T-cell Meeting, to be held in Palma de Mallorca, Spain from 12-14 February 2026. The promise of directing the immune system to precisely target malignancies is extraordinary, and clinical successes inspire for broader application. Yet, the path from concept to clinical reality remains complex, with challenges in manufacturing, delivery, long-term efficacy and safety. This meeting will bring together key opinion leaders, experts and stakeholders to navigate through the evolving landscape of CAR T therapies, focusing on the clinical successes and challenges, the management of toxicities, highlighting mechanisms and strategies for long-term safety and efficacy, recent scientific innovations and new indications.
Advances in Management of Retinoblastoma
ASPHO webinars connect learners to the latest in Pediatric Hematology/Oncology clinical treatment, best practices, and professional development.
Precision Oncology Workshop
Precision Oncology Workshop organized by PCPA
Multidisciplinary Radiopharmaceutical Therapy Symposium - From Start-Up to State-of-the-Art: A Collaborative Journey
We are excited to announce this new multidisciplinary symposium focused on the evolving utilization of and advancements in radiopharmaceuticals in the treatment of cancer and other indications.